模拟肽Gap27抑制缝隙连接蛋白43在帕金森病小鼠模型中的作用

doi:10.19723/j.issn.1671-167X.2022.03.005

摘要/Abstract

摘要：

目的: 探索在6-羟基多巴胺(6-hydroxydopamine，6-OHDA)诱导的帕金森病(Parkinson’s disease，PD)小鼠模型中，应用缝隙连接蛋白43(connexin 43，Cx43)选择性抑制剂模拟肽Gap27能否改善多巴胺神经元死亡以及对Cx43表达的影响。方法: 将18只C57BL/6小鼠随机分为对照组、6-OHDA组与6-OHDA+Gap27组，每组6只，进行双侧黑质脑立体定位注射。对照组注射抗坏血酸盐溶液，6-OHDA组注射6-OHDA溶液，6-OHDA+Gap27组注射6-OHDA和Gap27混合溶液，用免疫组织化学法对多巴胺神经元标志物酪氨酸羟化酶(tyrosine hydroxylase，TH)染色检测多巴胺神经元数量，实时荧光定量聚合酶链式反应(quantitative real-time polymerase chain reaction，qRT-PCR)检测Cx43信使核糖核酸(messenger ribonucleic acid，mRNA)表达，免疫荧光染色检测Cx43蛋白分布，Western blot法检测小鼠中脑Cx43蛋白及Cx43的第368位点丝氨酸磷酸化(Cx43 phosphorylation at serine 368，Cx43-ps368)蛋白含量。结果: 注射6-OHDA后，小鼠出现黑质多巴胺神经元大量死亡，6-OHDA组TH阳性神经元数量降为对照组的27.7%±0.02%(P < 0.01)，模拟肽Gap27的使用减少了多巴胺神经元死亡数量，6-OHDA+Gap27组TH阳性神经元数量为6-OHDA组的(1.64±0.16)倍(P < 0.05)；此外，6-OHDA引起Cx43蛋白含量增加，Cx43-ps368蛋白含量降低。Gap27减弱了6-OHDA引起的Cx43蛋白与Cx43-ps368蛋白含量变化，6-OHDA组中脑总Cx43蛋白含量为6-OHDA+Gap27组的(1.44±0.07)倍(P < 0.05)，为对照组的(1.68±0.07)倍(P < 0.01)，且6-OHDA组Cx43-ps368蛋白含量及占总Cx43蛋白比例显著低于6-OHDA+Gap27组(P＜0.05)。结论: 模拟肽Gap27在6-OHDA诱导的小鼠模型中可减少黑质多巴胺神经元死亡从而发挥神经保护作用，6-OHDA引起的Cx43蛋白过表达对多巴胺神经元可能存在神经毒性，而降低Cx43蛋白水平及维持Cx43-ps368蛋白水平可能是Gap27发挥保护作用的机制。

关键词: 缝隙连接蛋白43, 6-羟基多巴胺, 模拟肽Gap27, 帕金森病

Abstract:

Objective: To explore whether the using of mimetic peptide Gap27, a selective inhibitor of connexin 43 (Cx43), could block the death of dopamine neurons and influence the expression of Cx43 in 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease mouse models. Methods: Eighteen C57BL/6 mice were randomly divided into control group, 6-OHDA group and 6-OHDA+Gap27 group, with 6 mice in each group. Bilateral substantia nigra stereotactic injection was performed. The control group was injected with ascorbate solution, 6-OHDA group was injected with 6-OHDA solution, and 6-OHDA+Gap27 group was injected with 6-OHDA and Gap27 mixed solution. Immuno-histochemical staining was used to detect the number of dopamine neurons, quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of Cx43 messenger ribonucleic acid (mRNA), immuno-fluorescence staining was used to detect the distribution of Cx43 protein, the contents of Cx43 protein and Cx43 phosphorylation at serine 368 (Cx43-ps368) in mouse midbrain were detected by Western blot. Results: After injection of 6-OHDA, numerous dopamine neurons in substantia nigra died as Cx43 content increased, Cx43-ps368 content decreased. Mixing Gap27 while injecting 6-OHDA could reduce the number of death dopamine neurons and weaken the changes of Cx43 and Cx43-ps368 content caused by 6-OHDA. The number of tyrosine hydroxylase (TH) immunoreactive positive neurons in 6-OHDA group decreased to 27.7% ± 0.02% of the control group (P < 0.01); The number of TH immunoreactive positive neurons in 6-OHDA+Gap27 group was (1.64±0.16) times higher than that in 6-OHDA group (P < 0.05); The content of total Cx43 protein in 6-OHDA group was (1.44±0.07) times higher than that in 6-OHDA+Gap27 group (P < 0.05) while (1.68±0.07) times higher than that in control group (P < 0.01). In 6-OHDA group, the content of Cx43-ps368 protein and its proportion in total Cx43 protein were significantly lower than that in 6-OHDA+Gap27 group (P < 0.05). Conclusion: In 6-OHDA mouse models, mimetic peptide Gap27 played a protective role in reducing the damage to substantia nigra dopamine neurons, which was induced by 6-OHDA. The overexpression of Cx43 protein might have neurotoxicity to dopamine neuron. Meanwhile, decreasing Cx43 protein level and keeping Cx43-ps368 protein level may be the protective mechanisms of Gap27.

Key words: Connexin 43, 6-hydroxydopamine, Peptide Gap27, Parkinson's disease

中图分类号:

R392.3

权会会,徐卫星,祁宇泽,李清如,周辉,黄婧. 模拟肽Gap27抑制缝隙连接蛋白43在帕金森病小鼠模型中的作用[J]. 北京大学学报（医学版）, 2022, 54(3): 421-426.

Hui-hui QUAN,Wei-xing XU,Yu-ze QI,Qing-ru LI,Hui ZHOU,Jing HUANG. Inhibition connexin 43 by mimetic peptide Gap27 mediates protective effects on 6-hydroxydopamine induced Parkinson's disease mouse model[J]. Journal of Peking University (Health Sciences), 2022, 54(3): 421-426.

图/表 2

图1

图2

参考文献 24

1	Hayes MT . Parkinson's disease and Parkinsonism[J]. Am J Med, 2019, 132 (7): 802- 807. doi: 10.1016/j.amjmed.2019.03.001
2	Luo H , Xiang Y , Qu X , et al. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat mo-del of Alzheimer's disease through activation of BDNF-TrkB signaling pathway[J]. Front Pharmacol, 2019, 10, 395. doi: 10.3389/fphar.2019.00395
3	苏晓梅, 张丹参. 星形胶质细胞与神经退行性疾病的相关性[J]. 中国药理学与毒理学杂志, 2019, 33 (10): 868- 869.
4	Phatnani H , Maniatis T . Astrocytes in neurodegenerative disease[J]. Cold Spring Harb Perspect Biol, 2015, 7 (6): e020628. doi: 10.1101/cshperspect.a020628
5	Diaz EF , Labra VC , Alvear TF , et al. Connexin 43 hemichannels and pannexin-1 channels contribute to the α-synuclein-induced dysfunction and death of astrocytes[J]. Glia, 2019, 67 (8): 1598- 1619.
6	Orellana JA , Sáez PJ , Cortés-Campos C , et al. Glucose increases intracellular free Ca(2+) in tanycytes via ATP released through connexin 43 hemichannels[J]. Glia, 2012, 60 (1): 53- 68. doi: 10.1002/glia.21246
7	Leithe E , Mesnil M , Aasen T . The connexin 43 C-terminus: a tail of many tales[J]. Biochim Biophys Acta Biomembr, 2018, 1860 (1): 48- 64. doi: 10.1016/j.bbamem.2017.05.008
8	Evans WH , Boitano S . Connexin mimetic peptides: specific inhi-bitors of gap-junctional intercellular communication[J]. Biochem Soc Trans, 2001, 29 (Pt 4): 606- 612.
9	Li X , Zhao H , Tan X , et al. Inhibition of connexin43 improves functional recovery after ischemic brain injury in neonatal rats[J]. Glia, 2015, 63 (9): 1553- 1567. doi: 10.1002/glia.22826
10	Faniku C , O'Shaughnessy E , Lorraine C , et al. The connexin mimetic peptide gap27 and Cx43-knockdown reveal differential roles for connexin43 in wound closure events in skin model systems[J]. Int J Mol Sci, 2018, 9 (2): 604.
11	Evans WH , Leybaert L . Mimetic peptides as blockers of connexin channel-facilitated intercellular communication[J]. Cell Commun Adhes, 2007, 14 (6): 265- 273. doi: 10.1080/15419060801891034
12	Solan JL , Lampe PD . Connexin43 phosphorylation: structural changes and biological effects[J]. Biochem J, 2009, 419 (2): 261- 272. doi: 10.1042/BJ20082319
13	Ek-Vitorin JF , King TJ , Heyman NS , et al. Selectivity of conne-xin 43 channels is regulated through protein kinase C-dependent phosphorylation[J]. Circ Res, 2006, 98 (12): 1498- 1505. doi: 10.1161/01.RES.0000227572.45891.2c
14	黄焕焕, 赵雨佳, 张慧峰, 等. 抑制星形胶质细胞Cx43可保护LPS诱导的多巴胺神经元损伤[J]. 毒理学杂志, 2018, 32 (3): 186- 194.
15	Wang ZY , Lian H , Zhou L , et al. Altered expression of d1 and d2 dopamine receptors in vagal neurons innervating the gastric muscularis externa in a Parkinson's disease rat model[J]. J Parkinsons Dis, 2016, 6 (2): 317- 323. doi: 10.3233/JPD-160817
16	张蓓, 淫羊藿苷对6-OHDA诱导的帕金森病小鼠模型的保护作用及机制研究[D]. 贵州: 遵义医科大学, 2019.
17	Franklin-Keith BJ , Paxinos G . The mouse brain in stereotaxic coordinates[M]. 3th ed New York: Academic Press, 2007: 360
18	Cotter ML , Boitano S , Lampe PD , et al. The lipidated connexin mimetic peptide SRPTEKT-Hdc is a potent inhibitor of Cx43 channels with specificity for the pS368 phospho-isoform[J]. Am J Physiol, 2019, 317 (4): C825- C842. doi: 10.1152/ajpcell.00160.2019
19	Rufer M , Wirth SB , Hofer A , et al. Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated Parkinsonian mice[J]. J Neurosci Res, 1996, 46 (5): 606- 617. doi: 10.1002/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.0.CO;2-N
20	Kawasaki A , Hayashi T , Nakachi K , et al. Modulation of conne-xin 43 in rotenone-induced model of Parkinson's disease[J]. Neuroscience, 2009, 160 (1): 61- 68. doi: 10.1016/j.neuroscience.2009.01.080
21	Wang Y , Wu Z , Liu X , et al. Gastrodin ameliorates Parkinson's disease by downregulating connexin 43[J]. Mol Med Rep, 2013, 8 (2): 585- 590. doi: 10.3892/mmr.2013.1535
22	韩雪洁, 哈力达·巴合提汗, 高华, 等. 黄芩苷可影响帕金森病模型大鼠纹状体星形胶质细胞缝隙连接蛋白43的表达[J]. 中国组织工程研究, 2018, 22 (16): 2542- 2548. doi: 10.3969/j.issn.2095-4344.0222
23	Epifantseva I , Shaw RM . Intracellular trafficking pathways of Cx43 gap junction channels[J]. Biochim Biophys Acta Biomembr, 2018, 1860 (1): 40- 47. doi: 10.1016/j.bbamem.2017.05.018
24	Charron G , Doudnikoff E , Canron MH , et al. Astrocytosis in Parkinsonism: considering tripartite striatal synapses in physiopathology?[J]. Front Aging Neurosci, 2014, 6, 1- 12.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

[1]	祁宇泽,权会会,徐卫星,李清如,周辉. 苯并[a]芘对脑内多巴胺能神经元和α-突触核蛋白的影响及其机制[J]. 北京大学学报（医学版）, 2020, 52(3): 438-443.
[2]	刘小璇,张朔,刘娜,孙阿萍,张英爽,樊东升. 震颤分析用于早期帕金森病的诊断价值[J]. 北京大学学报（医学版）, 2019, 51(6): 1096-1102.
[3]	韩济生. 疼痛、药物成瘾和神经退行性疾病最新研究进展[J]. 北京大学学报（医学版）, 2009, 41(3): 249-254.
[4]	高红, 王建军, 张蔚, 蒋玉辉, 牛东滨, 王晓民. 重组胶质细胞源性神经营养因子腺病毒保护小鼠中脑多巴胺能神经元[J]. 北京大学学报（医学版）, 2003, 35(3): 256-260.
[5]	何其华, 周慧芳, 薛冰, 牛东滨, 王晓民. 雷公藤单体T10对谷氨酸所致PC12细胞损伤的保护作用及机制研究[J]. 北京大学学报（医学版）, 2003, 35(3): 252-255.
[6]	李凌松, 路艳艳. 神经干细胞及帕金森病的细胞治疗[J]. 北京大学学报（医学版）, 2002, 34(5): 499-505.